NO20060586L - 7-substituerte-3-nitro-pyrazol[1,5-a]pyrimidiner - Google Patents

7-substituerte-3-nitro-pyrazol[1,5-a]pyrimidiner

Info

Publication number
NO20060586L
NO20060586L NO20060586A NO20060586A NO20060586L NO 20060586 L NO20060586 L NO 20060586L NO 20060586 A NO20060586 A NO 20060586A NO 20060586 A NO20060586 A NO 20060586A NO 20060586 L NO20060586 L NO 20060586L
Authority
NO
Norway
Prior art keywords
pyrazolo
pyrimidines
nitro
substituted
gabaα
Prior art date
Application number
NO20060586A
Other languages
English (en)
Inventor
Antonio Guglietta
Luis Anglada
Albert Palomer
Marta Princep
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ES200301747A external-priority patent/ES2222814B1/es
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of NO20060586L publication Critical patent/NO20060586L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Det beskrives forbindelser med formel I: der r' er som angitt i kravene. Forbindelsen har spesifikk affinitet for GABAa reseptoren og er derfor brukbare ved terapi eller prevensjon av sykdommer som moduleres av tti- og a.2- GABAa reseptorene.
NO20060586A 2003-07-24 2006-02-06 7-substituerte-3-nitro-pyrazol[1,5-a]pyrimidiner NO20060586L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200301747A ES2222814B1 (es) 2003-07-24 2003-07-24 3-nitro-pirazolo(1,5-a)pirimidinas 7-sustituidas y composiciones y metodos relacionados.
ES200401696A ES2245893B1 (es) 2003-07-24 2004-07-12 Mejoras en el objeto de la patente de invencion n.p200301747 que se refiere a "3-nitro-pirazolo(1,5-a)pirimidinas 7-sustituidas y composiciones y metodos relacionados".
PCT/EP2004/008207 WO2005014596A1 (en) 2003-07-24 2004-07-22 7-substituted 3-nitro-pyrazolo `1,5-a! pyrimidines

Publications (1)

Publication Number Publication Date
NO20060586L true NO20060586L (no) 2006-02-06

Family

ID=34137683

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060586A NO20060586L (no) 2003-07-24 2006-02-06 7-substituerte-3-nitro-pyrazol[1,5-a]pyrimidiner

Country Status (15)

Country Link
US (1) US20070043064A1 (no)
EP (1) EP1648896B1 (no)
JP (1) JP2006528607A (no)
KR (1) KR20060030907A (no)
AT (1) ATE386040T1 (no)
AU (1) AU2004263277A1 (no)
BR (1) BRPI0412837A (no)
CA (1) CA2532431A1 (no)
DE (1) DE602004011780D1 (no)
HR (1) HRP20060008A2 (no)
MX (1) MXPA06000774A (no)
NO (1) NO20060586L (no)
TW (1) TWI252851B (no)
UY (1) UY28439A1 (no)
WO (1) WO2005014596A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050245517A1 (en) * 2004-04-29 2005-11-03 Phil Skolnick 2-pyridinyl[7-(substituted-pyridin-4-yl) pyrazolo[1,5-a]pyrimidin-3-yl]methanones
EP1884516A1 (en) * 2006-08-04 2008-02-06 Ferrer Internacional, S.A. Pyrazolo[1,5-a]pyrimidines, processes, uses and compositions
GB201223308D0 (en) 2012-12-21 2013-02-06 Univ Sunderland Enzyme inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE792533A (fr) * 1971-12-09 1973-06-08 Int Chem & Nuclear Corp Nouvelles pyrazolo (1,5a) pyrimidines et leur procede de preparation
US4626538A (en) * 1983-06-23 1986-12-02 American Cyanamid Company [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines
EP0264773A1 (en) * 1986-10-16 1988-04-27 American Cyanamid Company 4,5-dihydro and 4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidines
DE4333705C2 (de) * 1993-10-02 2003-10-30 Guenter Ege Arylmethylsubstituierte Pyrazolo-azine, insbesondere 3-Arylmethylpyrazolo[1,5-a]pyrimidine und Verfahren zur Herstellung von 8-Arylmethyl-pyrazolo[5,1-c][1,2,4]triazinen
US5538977A (en) * 1995-03-17 1996-07-23 American Cyanamid Company 3-Substituted-7-[3-(imidazol-1-yl)phenyl]-pyrazolo[1,5-a]pyrimidines
WO2000059908A2 (en) * 1999-04-06 2000-10-12 Du Pont Pharmaceuticals Company Pyrazolopyrimidines as crf antagonists
US6399621B1 (en) * 1999-08-10 2002-06-04 American Cyanamid Company N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
DE10153344A1 (de) * 2001-10-29 2003-05-15 Gruenenthal Gmbh Verwendung von substituierten Pyrazolopyrimidinen als Liganden von Nucleosid-Transport-Proteinen und/oder von Purinorezeptoren

Also Published As

Publication number Publication date
HRP20060008A2 (en) 2006-07-31
US20070043064A1 (en) 2007-02-22
CA2532431A1 (en) 2005-02-17
TWI252851B (en) 2006-04-11
DE602004011780D1 (de) 2008-03-27
JP2006528607A (ja) 2006-12-21
EP1648896B1 (en) 2008-02-13
ATE386040T1 (de) 2008-03-15
AU2004263277A1 (en) 2005-02-17
TW200504074A (en) 2005-02-01
KR20060030907A (ko) 2006-04-11
UY28439A1 (es) 2004-11-08
WO2005014596A1 (en) 2005-02-17
EP1648896A1 (en) 2006-04-26
BRPI0412837A (pt) 2006-09-26
MXPA06000774A (es) 2006-04-18

Similar Documents

Publication Publication Date Title
NO20062950L (no) 5,7-diaminopyrazolo `43-Dlpyrimidiner med PDE-5 inhiberende aktivitet
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
NO20054404L (no) 5,7-Diaminopyrazolo [4,3-D] Pyrimidiner Anvendelige ved behandling av of Hypertensjon
WO2004013120A8 (en) Novel benzodioxoles
NO20075624L (no) Nye histamin H3-reseptorligander og deres terapeutiske anvendelser
DE60330150D1 (en) Derivate des 2-trifluormethyl-6-aminopurins als phosphodiesterase 4 inhibitoren
GB0510143D0 (en) Novel compounds A1
SE0303180D0 (sv) Novel compounds
EA200300829A1 (ru) Производные 1-арил- или 1-алкилсульфонилбензазола в качестве лигандов 5-гидрокситриптамина-6
NO20062021L (no) Omleirede pentanoler, fremgangsmpte for fremstilling av dette, og deres anvendelse som antiflogistika
NO20060580L (no) N-[3-(3-substituerte-pyrazolo[1,5 a]pyrimidin-7-yl)- fenyl]-sulfonamider samt preparater og metoder relatert dertil
NO20054407L (no) Cannabinoid reseptor ligander og deres anvendelser
EA200700047A1 (ru) Новые алкильные производные в качестве метаботропных рецепторов глутамата
WO2005115392A8 (en) 3-(4-heteroarylcyclohexylamino) cyclopentanecarboxamides as modulators of chemokine receptors
HK1118534A1 (en) Thieno-pyrimidine compounds having fungicidal activity
NO20082096L (no) Azaindol-2-karboksamidderivativer
MX2007005611A (es) Compuestos de imidazo[1,2-a]piridina, composiciones, usos y metodos relacionados.
TW200519096A (en) Quinazoline analogs as receptor tyrosine kinase inhibitors
GEP20125637B (en) Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them
EA200300716A1 (ru) Гетероциклилалкилиндольные или -азаиндольные соединения в качестве лиганд 5-гидрокситриптамина-6
TW200609218A (en) Bicyclic compounds
DK1742950T3 (da) Pyrazolo-[4,3-D]-pyrimidiner
NO20082214L (no) 1,1-Diokso-tiomorfolinyl-indolyl-metanonderivater for anvendelse som H3-modulatorer
CO5680420A2 (es) Compuestos de 6-amino-1h-indazol y 4-aminobenzenofurano como inhibidores de la fosfodiesterasa 4
DE60221425D1 (de) Substituierte tetrazyklische pyprolochinolonderivate als phosphodiesterase-inhibitoren

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application